🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
601,32 USD
Máx. histórico
601,32
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
430,02 – 609,99
Variación hoy
+0,87%
Cierre anterior
596,13
Rango de hoy
596,14 – 606,16
Volumen hoy
595.233
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,54 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 7 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 18/09/2000 | 41,50 | 41,50 | 38,09 | 38,50 | -5,67% | 8,21% | 213.400 |
| 15/09/2000 | 39,56 | 41,00 | 39,56 | 40,81 | -3,47% | 3,63% | 491.000 |
| 14/09/2000 | 41,94 | 43,94 | 41,75 | 42,28 | +1,65% | 5,22% | 121.000 |
| 13/09/2000 | 42,00 | 42,50 | 41,00 | 41,59 | +0,99% | 3,57% | 214.800 |
| 12/09/2000 | 41,00 | 42,00 | 39,78 | 41,19 | +1,70% | 5,41% | 419.600 |
| 11/09/2000 | 40,50 | 43,50 | 39,50 | 40,50 | -3,57% | 9,88% | 1.169.400 |
| 08/09/2000 | 38,94 | 42,38 | 38,91 | 42,00 | +1,90% | 8,91% | 274.600 |
| 07/09/2000 | 38,50 | 41,25 | 38,50 | 41,22 | +7,15% | 7,14% | 1.123.000 |
| 06/09/2000 | 38,53 | 40,19 | 38,38 | 38,47 | -3,98% | 4,70% | 484.000 |
| 05/09/2000 | 42,50 | 43,00 | 39,97 | 40,06 | -7,37% | 7,13% | 1.072.000 |
| 01/09/2000 | 42,78 | 43,34 | 42,63 | 43,25 | +0,16% | 1,68% | 437.200 |
| 31/08/2000 | 41,03 | 43,18 | 40,75 | 43,18 | +5,56% | 5,92% | 655.800 |
| 30/08/2000 | 41,19 | 41,69 | 39,94 | 40,91 | -1,58% | 4,25% | 850.200 |
| 29/08/2000 | 43,31 | 43,75 | 38,13 | 41,56 | +3,91% | 12,99% | 2.723.200 |
| 28/08/2000 | 45,94 | 46,50 | 35,25 | 40,00 | -11,17% | 24,49% | 4.736.000 |
| 25/08/2000 | 46,69 | 48,00 | 45,00 | 45,03 | -3,87% | 6,43% | 920.400 |
| 24/08/2000 | 47,50 | 48,09 | 46,00 | 46,84 | +1,83% | 4,41% | 507.400 |
| 23/08/2000 | 46,69 | 46,75 | 45,75 | 46,00 | +0,27% | 2,14% | 237.400 |
| 22/08/2000 | 46,97 | 47,06 | 45,75 | 45,88 | -2,39% | 2,79% | 263.600 |
| 21/08/2000 | 46,50 | 47,16 | 45,10 | 47,00 | +1,83% | 4,42% | 210.200 |
| 18/08/2000 | 47,75 | 47,75 | 46,03 | 46,16 | -1,66% | 3,60% | 273.800 |
| 17/08/2000 | 45,50 | 47,75 | 45,50 | 46,94 | +3,44% | 4,95% | 244.000 |
| 16/08/2000 | 45,19 | 45,50 | 44,94 | 45,38 | +0,07% | 1,24% | 537.200 |
| 15/08/2000 | 45,75 | 45,75 | 44,69 | 45,34 | -0,34% | 2,32% | 553.800 |
| 14/08/2000 | 46,06 | 46,56 | 43,03 | 45,50 | -0,55% | 7,67% | 1.118.600 |
| 11/08/2000 | 47,00 | 47,56 | 45,25 | 45,75 | -2,66% | 4,92% | 452.800 |
| 10/08/2000 | 48,38 | 48,38 | 46,61 | 47,00 | -1,38% | 3,65% | 445.200 |
| 09/08/2000 | 50,91 | 51,00 | 47,56 | 47,66 | -3,66% | 6,75% | 445.600 |
| 08/08/2000 | 55,50 | 56,00 | 47,55 | 49,47 | -12,35% | 15,23% | 787.600 |
| 07/08/2000 | 52,38 | 56,50 | 51,50 | 56,44 | +8,76% | 9,55% | 382.200 |